Ann: Quarterly Activities Report, page-20

First 20 Last

Share
Profile

Follow
IntenseOnlooker

320 Posts.

244

06/08/18

09:45

Post #: 34738467
Share

Originally posted by djm3001 ↑

Not sure what rumour you are accusing me of spreading in your opening paragraph but assume it is baseless as usual.

I did state that the high court had handed down a ruling on the 18th July dismissing all of the applications Axiom had made for their contempt action.

I further said that the court had awarded full costs for the entire process to Sumitomo and these costs included an overseas Queens Counsel and 2 overseas Junior barristers and obviously their instructing solicitors. That will be a very large amount of money and I notice that no budget or mention was made about it in the quarterly update.

You said that you spoke to the Axiom head office and they told you unequivocally that NO ruling had been made whatsoever on the case. It would seem strange that they are unaware that a ruling has been issued. .

Please find attached a copy of the ruling handed down on 18th July by Justice Faukona dismissing all of Axiom's applications for documents and ordering all costs against them. You will note that in his judgement he refers to the applications as "fishing expeditions" and "of no merit".

View attachment 1223604
The court dismissed all the applications and ordered the material to be returned to google and telekom and awarded full costs to SMM for the whole process since 2016.

Reading the ruling it is obvious that Axioms whole case relied on having access to that information to prove a nexus between the SMM employee and SMM management. Without it the case would be weak to non existent IMO.

I would suggest that it is not me who is trying to deceive people. :}

maybe you should talk to the Axiom office again.

Expand

djm, this disinformation and defamation case against Sumitomo, even if you were right, will have no material impact on Axiom’s bright future. Do not lose sight of the wood for the trees, please!

AVQ Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 20 Last

Add AVQ (ASX) to my watchlist

Ann: Quarterly Activities Report, page-20

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Banshee's historic trenches prove rich in antimony and gold for GDM

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News